Ticker brief
CADL
last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
5
authors 14d
5
No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.
Sentiment — last 14 days
daily mean sentiment, 2026-06-30 → 2026-07-01 · now +0.30 (−1 bearish … +1 bullish)
Who spoke5
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @CrweWorld | C | · | 1 | +0.30 |
| @ABBONews | C | · | 1 | +0.25 |
| @OzmosiHealth | C | · | 1 | +0.25 |
| @BiopharmIQ | B | · | 1 | +0.15 |
| @PrismMarketView | C | · | 1 | +0.30 |
Recent signals5of 5 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-07-01 | @PrismMarketView | +0.30 | CADL initiated global pivotal Phase 3 AURORA trial across 150+ sites. | · | tweet ↗ |
| 2026-06-30 | @BiopharmIQ | +0.15 | Biotech open news list with positive percentage moves and catalysts. | · | tweet ↗ |
| 2026-06-30 | @OzmosiHealth | +0.25 | Candel announces initiation of global pivotal Phase 3 AURORA trial in NSCLC. | · | tweet ↗ |
| 2026-06-30 | @ABBONews | +0.25 | Candel initiated global Phase 3 AURORA trial for lung cancer combination therapy. | · | tweet ↗ |
| 2026-06-30 | @CrweWorld | +0.30 | Candel starts global pivotal Phase 3 AURORA trial in lung cancer. | · | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.